View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Neuromuscular Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
May 01, 2024
2 min read
Save

Accelerometers may be reliable tool for measuring ALS disease progression

Accelerometers may be reliable tool for measuring ALS disease progression

Wearable accelerometers may be a reliable tool to track disease progression in patients with amyotrophic lateral sclerosis, researchers wrote in The Lancet.

SPONSORED CONTENT
May 01, 2024
1 min read
Save

FDA approves Ingrezza sprinkle capsules for tardive dyskinesia, Huntington’s chorea

FDA approves Ingrezza sprinkle capsules for tardive dyskinesia, Huntington’s chorea

The FDA has approved Ingrezza sprinkle capsules to treat adults with Huntington’s disease chorea or tardive dyskinesia, according to a press release from the manufacturer.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
April 26, 2024
1 min read
Save

Combination ALS therapeutic nonsuperior to placebo in phase 3 clinical trial

Combination ALS therapeutic nonsuperior to placebo in phase 3 clinical trial

DENVER — A combination therapeutic for amyotrophic lateral sclerosis was nonsuperior to placebo over 48 weeks in a phase 3 clinical trial, according to a presenter at the American Academy of Neurology annual meeting.

SPONSORED CONTENT
April 25, 2024
4 min watch
Save

VIDEO: Troriluzole alters trajectory of spinocerebellar ataxia

VIDEO: Troriluzole alters trajectory of spinocerebellar ataxia

DENVER — Four studies presented at the American Academy of Neurology annual meeting show improvements in patients with spinocerebellar ataxia who take troriluzole.

SPONSORED CONTENT
April 19, 2024
1 min read
Save

FDA clears investigational new drug application for Fragile X treatment

FDA clears investigational new drug application for Fragile X treatment

The FDA has cleared an investigational new drug application for a small molecule therapeutic to treat those with Fragile X syndrome, according to the manufacturer.

SPONSORED CONTENT
April 16, 2024
1 min read
Save

IV efgartigimod improves daily functionality in generalized myasthenia gravis

IV efgartigimod improves daily functionality in generalized myasthenia gravis

DENVER — Treatment with IV efgartigimod improved functionality for individuals with acetylcholine receptor-positive generalized myasthenia gravis, according to a poster from the American Academy of Neurology annual meeting.

SPONSORED CONTENT
April 04, 2024
1 min read
Save

Amylyx pulls ALS drug Relyvrio from market in US, Canada

Amylyx pulls ALS drug Relyvrio from market in US, Canada

Amylyx Pharmaceuticals Inc. announced Relyvrio, its amyotrophic lateral sclerosis therapeutic, will be removed from the market in the United States and Canada, effective immediately.

SPONSORED CONTENT
April 02, 2024
1 min read
Save

Intra-molecular compound advanced as potential disease-modifying therapy for ALS

Intra-molecular compound advanced as potential disease-modifying therapy for ALS

A Cincinnati-based life sciences company announced that one of its development candidates, ASHA-624, will be advanced as a potential disease modifying therapy for amyotrophic lateral sclerosis.

SPONSORED CONTENT
March 27, 2024
2 min read
Save

Multiple Sclerosis Awareness Month: Latest research, treatments from ACTRIMS 2024

Multiple Sclerosis Awareness Month: Latest research, treatments from ACTRIMS 2024

March is Multiple Sclerosis Awareness Month, a time to improve knowledge of and highlight the growing treatment options for progressive types of this degenerative disease.

SPONSORED CONTENT
March 25, 2024
1 min read
Save

Partnership aims to commercialize brain-computer interface technology

Partnership aims to commercialize brain-computer interface technology

A Boston-area developer of brain-computer interface technology and a Canadian biotech firm have announced a collaboration to globally commercialize the former’s brain health tools.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails